Skyline Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 103
  • Portfolio
  • 1
  • Exits
  • 61
Exits

Skyline Ventures General Information

Description

Skyline Ventures is a venture capital firm that specializes in investing in product-focused healthcare companies. They prefer to invest in small molecule and protein therapeutics, medical devices, diagnostics, and technologies that facilitate drug discovery and life science research. The firm was founded in 1997 and is based in Palo Alto, California.

Contact Information

Year Founded
1997
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • 525 University Avenue
  • Suite 1350
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Skyline Ventures Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mediterráneo Servicios de Gestión Inmobiliaria 29-Oct-2018 Buyout/LBO Buildings and Property Profitable
00000 000000000 26-Jul-2018 00000 00000 000.00 Drug Delivery Generating Revenue/Not Profitable 0000 0000 00.0
0000000 0000000000 11-Apr-2017 0000 0000 Pharmaceuticals Generating Revenue/Not Profitable 0000000 0000000 00.0
00-0000 15-Apr-2015 00000 00000 0000 Surgical Devices Generating Revenue/Not Profitable 00000 000000
000000000 00000000 05-Mar-2015 00000 00000 0000 Pharmaceuticals Profitable 0000 000000 00
000000 25-Jun-2014 00 000000000 00.00 Electronic Equipment and Instruments Generating Revenue 0000 000000 00
0000000 0000000000 28-May-2014 00000 00000 000.00 Pharmaceuticals Generating Revenue 00000 0000 00.0
00-0000 28-Apr-2014 00000 00000 000.00 Surgical Devices Generating Revenue/Not Profitable 00000 000000
Sutro Biopharma 11-Dec-2013 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable 0000 0000 00.0
Dicerna Pharmaceuticals 01-Aug-2013 Later Stage VC 0000 Pharmaceuticals Generating Revenue/Not Profitable 0000000 0000000 00.0
You’re viewing 10 of 103 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Skyline Ventures Exits (61)

Company Name Exit Date Exit Type Exit Size
Proteon Therapeutics 09-Jan-2020 Merger/Acquisition 000.00
00-0000 17-Oct-2018 000 00000
00000 000000000 27-Sep-2018 000 0000
000000 00000000000 23-Apr-2018 000000000 00000000
000000000 00000000 13-Apr-2018 000000000 00000000
0000000 0000000000 31-Mar-2018 000000000 00000000
0000000 0000000000 31-Mar-2018 000000000 00000000
000000000 05-Sep-2017 000000000000000000
Concert Pharmaceuticals 31-Jan-2017 Secondary Transaction - Open Market
Hansen Medical 27-Jul-2016 Merger/Acquisition 00000
You’re viewing 10 of 61 exits. Get the full list »

Skyline Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Skyline Ventures‘s full profile, request access.

Request a free trial

Skyline Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Skyline Ventures Team (9)

Name Title Deals Funds Boards Office
Kerry Kenny Vice President of Finance & Operations & Chief Financial Officer Palo Alto, CA
Yasunori Kaneko MD Managing Director 0 0 0 Palo Alto, CA
John Freund MD Founder & Managing Partner 00 0 0 Palo Alto, CA
Eric Gordon Ph.D Partner 0 0 Palo Alto, CA
You’re viewing 4 of 9 team members. Get the full list »

Skyline Ventures Co-Investors (12)

Name With Exits Lead Partner Series Industry
Alta Partners 1 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 Series chart Industry bar
Lilly Ventures 0 0 Series chart Industry bar
Merck 0 0 Series chart Industry bar
You’re viewing 5 of 12 co-investors. Get the full list »